心力衰竭住院患者的特征,医疗保健利用率和费用
Hanna Winkler1, Dorothee Riedlinger2, Andrea Figura3
1Institute of Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
Frontiers in health services
|May 9, 2025
概括
住院治疗心力衰竭是常见的和昂贵的. 持续的门诊护理和基于指导方针的药物显著减少住院和死亡率,改善患者的治疗结果,降低医疗保健费用.
科学领域:
- 心脏病学 心脏病学
- 医疗保健服务研究 医疗服务研究
- 公共卫生 公共卫生
背景情况:
- 由于心力衰竭而住院的情况很常见,随着疾病的严重程度而升级.
- 了解患者的特征和医疗保健利用对于管理高风险心力衰竭患者至关重要.
- 心力衰竭患者的高发病率和死亡率导致了大量的医疗保健费用.
研究的目的:
- 分析心力衰竭患者的特征和医疗保健利用模式.
- 确定2016年心力衰竭患者的累积成本和相关医疗利用情况.
- 调查持续的门诊护理对住院和死亡率的影响.
主要方法:
- 来自柏林八家医院的EMANet数据集的二次数据分析.
- 将医院信息系统 (HIS) 数据与2016年法定医疗保险基金的个人健康索赔联系起来.
- 对来自970名心力衰竭患者的健康声明数据的分析.
主要成果:
- 心力衰竭患者的年死亡率为23.9%.
- 每年医疗保健总费用达到33,668欧元,其中69%归因于医院治疗.
- 患者平均住院时间为37天,其中有10天是无计划心血管事件.
- 持续的门诊护理和基于指南的药物治疗与减少住院和死亡率有关.
结论:
- 心力衰竭患者面临着高的疾病负担,死亡率和相关的医疗费用.
- 心力衰竭严重程度的增加显著提高了医疗保健成本和资源利用率.
- 实施持续的门诊护理可能会减轻疾病负担并减少医疗保健支出.
相关概念视频
Pathophysiology of Heart Failure
1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
Heart Failure Drugs: β-Blockers
278
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
278
Heart Failure Drugs: Diuretics
294
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
294
Imbalances in Cardiac Output
1.2K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to...
1.2K
Pulse rhythm
721
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
721
Heart Failure Drugs: Inotropic Agents
424
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
424


